Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.

<h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolina Alquezar, Noemí Esteras, Ainhoa Alzualde, Fermín Moreno, Matilde S Ayuso, Adolfo López de Munain, Ángeles Martín-Requero
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8cfb0f14389d4adf9d517184e2e3f24f
record_format dspace
spelling oai:doaj.org-article:8cfb0f14389d4adf9d517184e2e3f24f2021-11-18T07:18:12ZInactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.1932-620310.1371/journal.pone.0037057https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22623979/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activity of cyclin-dependent kinase (CDK) CDK6/pRb pathway in lymphoblasts expressing the c.709-1G>A PGRN mutation. Since members of the CDK family appear to play a role in neurodegenerative disorders and in apoptotic death of neurons subjected to various insults, we investigated the role of CDK6/pRb in cell survival/death mechanisms following serum deprivation.<h4>Methodology/principal findings</h4>We performed a comparative study of cell viability after serum withdrawal of established lymphoblastoid cell lines from control and carriers of c.709-1G>A PGRN mutation, asymptomatic and FTLD-TDP diagnosed individuals. Our results suggest that the CDK6/pRb pathway is enhanced in the c.709-1G>A bearing lymphoblasts. Apparently, this feature allows PGRN-deficient cells to escape from serum withdrawal-induced apoptosis by decreasing the activity of executive caspases and lowering the dissipation of mitochondrial membrane potential and the release of cytochrome c from the mitochondria. Inhibitors of CDK6 expression levels like sodium butyrate or the CDK6 activity such as PD332991 were able to restore the vulnerability of lymphoblasts from FTLD-TDP patients to trophic factor withdrawal.<h4>Conclusion/significance</h4>The use of PGRN-deficient lymphoblasts from FTLD-TDP patients may be a useful model to investigate cell biochemical aspects of this disease. It is suggested that CDK6 could be potentially a therapeutic target for the treatment of the FTLD-TDP.Carolina AlquezarNoemí EsterasAinhoa AlzualdeFermín MorenoMatilde S AyusoAdolfo López de MunainÁngeles Martín-RequeroPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e37057 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carolina Alquezar
Noemí Esteras
Ainhoa Alzualde
Fermín Moreno
Matilde S Ayuso
Adolfo López de Munain
Ángeles Martín-Requero
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
description <h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activity of cyclin-dependent kinase (CDK) CDK6/pRb pathway in lymphoblasts expressing the c.709-1G>A PGRN mutation. Since members of the CDK family appear to play a role in neurodegenerative disorders and in apoptotic death of neurons subjected to various insults, we investigated the role of CDK6/pRb in cell survival/death mechanisms following serum deprivation.<h4>Methodology/principal findings</h4>We performed a comparative study of cell viability after serum withdrawal of established lymphoblastoid cell lines from control and carriers of c.709-1G>A PGRN mutation, asymptomatic and FTLD-TDP diagnosed individuals. Our results suggest that the CDK6/pRb pathway is enhanced in the c.709-1G>A bearing lymphoblasts. Apparently, this feature allows PGRN-deficient cells to escape from serum withdrawal-induced apoptosis by decreasing the activity of executive caspases and lowering the dissipation of mitochondrial membrane potential and the release of cytochrome c from the mitochondria. Inhibitors of CDK6 expression levels like sodium butyrate or the CDK6 activity such as PD332991 were able to restore the vulnerability of lymphoblasts from FTLD-TDP patients to trophic factor withdrawal.<h4>Conclusion/significance</h4>The use of PGRN-deficient lymphoblasts from FTLD-TDP patients may be a useful model to investigate cell biochemical aspects of this disease. It is suggested that CDK6 could be potentially a therapeutic target for the treatment of the FTLD-TDP.
format article
author Carolina Alquezar
Noemí Esteras
Ainhoa Alzualde
Fermín Moreno
Matilde S Ayuso
Adolfo López de Munain
Ángeles Martín-Requero
author_facet Carolina Alquezar
Noemí Esteras
Ainhoa Alzualde
Fermín Moreno
Matilde S Ayuso
Adolfo López de Munain
Ángeles Martín-Requero
author_sort Carolina Alquezar
title Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
title_short Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
title_full Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
title_fullStr Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
title_full_unstemmed Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
title_sort inactivation of cdk/prb pathway normalizes survival pattern of lymphoblasts expressing the ftld-progranulin mutation c.709-1g>a.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f
work_keys_str_mv AT carolinaalquezar inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT noemiesteras inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT ainhoaalzualde inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT ferminmoreno inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT matildesayuso inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT adolfolopezdemunain inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
AT angelesmartinrequero inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga
_version_ 1718423678046175232